Not So Different: A Podcast From The Center For Biosimilars

S5 Ep13: New Year, New Hurdles: What's in Store for Biosimilars in 2023

Informações:

Sinopsis

To read more about adalimumab biosimilars, click here. To read more about ophthalmology biosimilars, click here. To learn more about the Inflation Reduction Act’s impact on biosimilars, click here. To read more about the reauthorization of the Biosimilars User Fee Amendment, click here. To learn more about interchangeability, click here.